SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
ZyVersa Unveils Groundbreaking Potential of Inflammasome Inhibitors in Combination with GLP-1 Agonists to Address Unmet Medical Needs of People Living with Obesity; Provides R&D Update
May 7, 2025
 · 
8 min read
Press Releases
Viatris Announces Quarterly Dividend
May 7, 2025
 · 
3 min read
Press Releases
Genprex Signs Sponsored Research Agreement with the University of Pittsburgh to Study Diabetes Gene Therapy in Type 1 and Type 2 Diabetes
May 7, 2025
 · 
8 min read
Press Releases
PAQ Therapeutics Appoints Andrew Krivoshik, MD, PhD, as Chief Medical Officer, Announces Addition of Eric Rubin, MD, and Piro Lito MD, PhD, to Advisory Board
May 7, 2025
 · 
3 min read
Press Releases
PAQ Therapeutics Announces $39 Million Series B Financing and Initiates Phase 1 Trial to Advance Novel Approach Addressing KRAS-Driven Cancers with High Unmet Need
May 7, 2025
 · 
3 min read
Press Releases
Theriva™ Biologics Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE Phase 2b Clinical Trial of VCN-01 with Gemcitabine/nab-Paclitaxel in Newly-Diagnosed Metastatic Pancreatic Cancer Patients
May 7, 2025
 · 
11 min read
Press Releases
Benchling and Moderna Collaborate on AI-Driven Research
May 7, 2025
 · 
2 min read
Press Releases
Endo Reports First-Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance
May 7, 2025
 · 
30 min read
Press Releases
EyePoint Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Developments
May 7, 2025
 · 
13 min read
Press Releases
Amarin Reports First Quarter 2025 Financial Results
May 7, 2025
 · 
19 min read
Press Releases
Amicus Therapeutics to Present at the Bank of America 2025 Health Care Conference
May 7, 2025
 · 
1 min read
Press Releases
Atea Pharmaceuticals Announces Full Results from Phase 2 Study of Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus (HCV) Presented at EASL Congress 2025
May 7, 2025
 · 
13 min read
Press Releases
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
May 7, 2025
 · 
2 min read
Press Releases
Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved
May 7, 2025
 · 
50 min read
Press Releases
Immunocore reports first quarter financial results and provides a business update
May 7, 2025
 · 
25 min read
Press Releases
Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies
May 7, 2025
 · 
5 min read
Press Releases
Seres Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates
May 7, 2025
 · 
17 min read
Press Releases
Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City
May 7, 2025
 · 
2 min read
Press Releases
Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025
May 7, 2025
 · 
1 min read
Press Releases
Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
May 7, 2025
 · 
6 min read
Press Releases
Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results
May 7, 2025
 · 
19 min read
Press Releases
Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance
May 7, 2025
 · 
17 min read
Press Releases
Lirum Therapeutics Announces New LX-101 Data in Thyroid Eye Disease Selected for Presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting
May 7, 2025
 · 
5 min read
Press Releases
Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update
May 7, 2025
 · 
20 min read
Press Releases
Arrowhead Pharmaceuticals to Participate in May 2025 Investor Conferences
May 7, 2025
 · 
4 min read
Press Releases
Precision BioSciences Announces Presentation of Initial Safety Data from the Phase 1 ELIMINATE-B Trial Evaluating PBGENE-HBV at the 2025 European Association for the Study of the Liver Congress (EASL)
May 7, 2025
 · 
10 min read
Press Releases
Ironwood Pharmaceuticals Reports First Quarter 2025 Results
May 7, 2025
 · 
19 min read
Press Releases
VectorY Therapeutics to Present Preclinical Data on Novel ALS Therapeutic Strategy at Target ALS Conference in Boston
May 7, 2025
 · 
3 min read
Press Releases
Charles River Laboratories Announces First-Quarter 2025 Results
May 7, 2025
 · 
19 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery showed statistically significant and clinically meaningful improvement in pathologic complete response in high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11
May 7, 2025
 · 
19 min read
Press Releases
Bruker Reports First Quarter 2025 Financial Results
May 7, 2025
 · 
19 min read
Press Releases
Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights
May 7, 2025
 · 
18 min read
Press Releases
Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value
May 7, 2025
 · 
10 min read
Press Releases
Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows
May 7, 2025
 · 
5 min read
Load More